Nascent Pharma Holdings, Inc.

10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K Entered a material agreement; Delisting notice or listing-rule failure; Modified rights of security holders; Director or officer change; Amended charter or bylaws Oct 28, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024 10-Q/A Quarter ended 2024-03-31 Jul 17, 2024 8-K Exit or disposal costs Jun 18, 2024 8-K Changed accountants May 31, 2024 10-Q Quarter ended 2024-03-31 May 20, 2024 8-K Changed accountants May 6, 2024 10-K Fiscal year ended 2023-12-31 Apr 15, 2024 8-K Took on a direct financial obligation Mar 21, 2024 8-K Completed an acquisition or disposition Mar 20, 2024 8-K Other events Mar 6, 2024 8-K Other events Mar 1, 2024 8-K Other events Jan 16, 2024 8-K Other events Dec 26, 2023 8-K Triggering event accelerating an obligation Dec 5, 2023 10-Q Quarter ended 2023-09-30 Nov 20, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Nov 3, 2023 8-K Other events Oct 10, 2023 10-Q Quarter ended 2023-06-30 Aug 21, 2023 10-Q Quarter ended 2023-03-31 May 22, 2023 10-K Fiscal year ended 2022-12-31 Apr 17, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 9, 2023 10-Q Quarter ended 2022-09-30 Nov 21, 2022 10-Q Quarter ended 2022-06-30 Aug 22, 2022 8-K Entered a material agreement Jul 25, 2022 8-K Regulation FD disclosure Jul 13, 2022 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 15, 2022 10-Q Quarter ended 2022-03-31 May 17, 2022 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 29, 2022 10-K Fiscal year ended 2021-12-31 Apr 15, 2022 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 31, 2022 8-K Entered a material agreement Mar 4, 2022 8-K Entered a material agreement Mar 4, 2022 10-Q Quarter ended 2021-09-30 Nov 5, 2021 8-K Entered a material agreement Sep 30, 2021 8-K Regulation FD disclosure Sep 27, 2021 8-K Entered a material agreement Sep 1, 2021 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Other events Aug 17, 2021 10-Q Quarter ended 2021-06-30 Aug 16, 2021